Project Grant R01EY036826

Award Date 1/1/25
Completion Date 12/31/29
Dollars Obligated $400K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
The National Eye Institute (NEI) awarded a $131,281 Project Grant under the Vision Research program (CFDA 93.867) to Northwestern University to support research on the role of myeloid cell transendothelial migration in non-proliferative diabetic retinopathy. The research aims to determine whether and when blocking CCL2-driven myeloid cell infiltration can halt the progression of inflammation in the mouse retina, and whether blocking leukocyte-endothelial interactions early in the disease...
This $421,600 Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) will support research at Tufts Medical Center in Boston, MA to investigate the regulatory mechanisms governing retinal neovascularization. The research aims to delineate the role of chemokine signaling in recruiting peripheral immune cells to facilitate pathological vascular growth, as well as the role of microglial complement receptors in regulating neovessel regression. The project will utilize...
The U.S. National Eye Institute (NEI) awarded a $184,117 Project Grant (CFDA 93.867 - Vision Research) to Oakland University to determine the role of G-coupled protein receptors GPR31 and GPR39 in the pathogenesis of diabetic retinopathy. The project aims to investigate the affinities and substrate specificities of GPR31 and GPR39 for 12- and 15-HETE metabolites in retinal endothelial cells and Müller cells under normal and hyperglycemic conditions. It will also examine the effects of GPR31 or...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $247,700 to the University of Utah to establish a chimeric mouse model to study human retinal microglia in vivo. The key objectives are to: Characterize the engraftment and distribution of human xenotransplanted microglia in the mouse retina and optic nerve, and assess the impact on host retinal cells and tissue organization. Use single-cell RNA sequencing to define the transcriptome of the human...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $253,500.00 to the Icahn School of Medicine at Mount Sinai to reconstruct a human blood-retina barrier and perfused vascular system. The goal is to investigate the role of apolipoprotein E (APOE) variants in age-related macular degeneration (AMD), a leading cause of vision loss. The research aims to optimize an in vitro outer blood-retina barrier model, generate isogenic models with different APOE...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) to Northwestern University provides $540,971 to support research on the classification and sub-cellular compartmentalization of displaced amacrine cells in the mouse retina. The key objectives are to: Establish a multimodal classification of displaced amacrine cell types by aligning morpho-electric data with single-cell RNA sequencing clusters. Use two-photon calcium imaging to measure functional...
This Project Grant award from the National Eye Institute (NEI) of the National Institutes of Health (CFDA 93.867 - Vision Research) provides $658,889 to the University of Rochester to investigate the role of the pro-inflammatory enzyme PLA2G2A/sPLA2-IIA in age-related macular degeneration (AMD). The research aims to utilize human donor eyes, patient-derived induced pluripotent stem cells, and transgenic mouse models to critically evaluate the mutation-independent pathogenic role of PLA2G2A in...
The National Eye Institute (NEI), under the Department of Health and Human Services, awarded a $440,806 Project Grant (CFDA 93.867 - Vision Research) to The Research Foundation for the State University of New York (RF SUNY) to study the role of the molecular chaperone p58IPK in retinal neurons under diabetic conditions. The goal is to define the in vivo function of p58IPK in regulating protein and lipid homeostasis through the integrated stress response and lipid glycosylation pathways, and to...
The National Eye Institute (NEI) awarded a $603,488 Project Grant (CFDA 93.867 - Vision Research) to Versiti Wisconsin, Inc. to conduct research on the role of the protein Rap1B in regulating inflammation and homeostasis in retinal endothelial cells. The project aims to: Assess how Rap1B influences the organization and signaling of lipid rafts containing the VEGF receptor VEGFR2, which is critical for maintaining endothelial health. Examine how Rap1B controls the balance between VEGFR2 and...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports research to investigate the role of Müller glia in the retinal inflammatory response to stress, injury, and disease. The $606,034 award to St. Jude Children's Research Hospital Inc. will fund a 5-year study to profile the acute and chronic inflammatory pathways in the retina across various disease models, with a focus on the coordinating function of Müller glia. The research aims to...

This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $400,000 to Northwestern University to investigate the role of retinal perivascular macrophages in the blood-retina barrier and their function during inflammatory retinal diseases such as diabetic retinopathy and uveitis. The key objectives are to: 1) determine the ontological origin and longevity of retinal perivascular macrophages, 2) evaluate their role in experimental autoimmune uveitis, and 3) assess their function in diabetic retinopathy. The award commenced on January 1, 2025 and is scheduled for completion on December 31, 2029. This research aims to advance the understanding of perivascular macrophages and their blood-retina barrier functions, which could open new therapeutic approaches for inflammatory retinal diseases.

Generated 8/5/25, 5:10 AM